Clinical Trials · NCT00182754
Octreotide in Treating Patients With Cancer-Related Malignant Ascites
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Alliance for Clinical Trials in Oncology
- Enrollment
- 33
- Start date
- Oct 2005
- Locations
- 122 sites, United States
- Primary endpoint
- Median Time to Paracentesis